Turning Innovation Into Adoption Through Evidence
  • Home
  • Our Services
  • More
    • Home
    • Our Services
Turning Innovation Into Adoption Through Evidence
  • Home
  • Our Services

Achieve Your Business Goals with ETI

Evidence Generation

Digital Health Technologies

Advisory & Due Diligence

 

"We have data. We're not sure what evidence we actually need ." 


Evidence Master Plan

 Fit-for-purpose evidence planning  from first study to final submission.  A prioritised end-to-end evidence roadmap aligned to your regulatory, payer, and clinical goals.  


Statistical Strategy & Oversight

Endpoint selection,  study design input, and DSMB-ready reporting for Phase II–IV programmes.


Integrated Summary of Evidence

A clear, auditable narrative connecting trial data, RWE, and biomarker findings for regulatory review.


Publication & Communication Strategy

Support for translating study results into peer-reviewed publications and stakeholder-ready scientific communications.

Advisory & Due Diligence

Digital Health Technologies

Advisory & Due Diligence


"We're evaluating an asset and need an independent scientific read — quickly." 


Evidence Due Diligence Report

Independent assessment of study design quality, data integrity, regulatory exposure, and claimed outcome credibility.



Evidence Gap Analysis

A clear map of what evidence exists, what is missing, and what it would take to fill the gaps before the next milestone.



Scientific Advisory Facilitation

Structured KOL or expert advisory sessions that surface the critical questions a deal team needs answere

Digital Health Technologies

Digital Health Technologies

Digital Health Technologies


"The FDA and CE mark pathways for our SaMD are unclear..." 

 

FDA Pre-submission Package

Q-Sub evidence strategy, evidence gap analysis, and meeting preparation to align with FDA before you spend on studies.


CE Mark Technical File Support

MDR/IVDR clinical evaluation strategy, PMCF planning, and TÜV-SUD interaction support.


Clinical Validation Plan

Fit-for-purpose study design that satisfies 510(k), De Novo, or PMA requirements without over-engineering.


Post-market Clinical Follow-up Plan

PMCF and PASS protocols that satisfy regulators and generate commercially useful long-term safety and outcomes data.  


AI Algorithm Evidence Dossier

Analytical validation, clinical performance evidence, and bias assessment for AI/ML-based medical algorithms.

Capability Building

Market Access & Reimbursement

Digital Health Technologies

 "Our team runs studies but doesn't yet think strategically about evidence."

 

Trainings

Workshops and mentorship programmes that build strategic thinking alongside technical execution skills.


Statistical Methods Consultation

Expert input on study design, endpoint selection, adaptive methods, and regulatory-grade analysis approaches.



Market Access & Reimbursement

Market Access & Reimbursement

Market Access & Reimbursement

"Our product got approved. Payers still won't cover it." 

 

Reimbursement Evidence Package

Economic and outcomes evidence structured for payer coverage submissions and HTA review.

Real-world Data & Insights

Market Access & Reimbursement

Market Access & Reimbursement

"We know real-world evidence matters. We don't know where to start ..."
 

RWE Study Package

 RWE strategy, data source selection, protocols and analysis plan, CRO oversight for claims, EHR, and registry studies . 


Copyright © 2026 E2I - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept